Clinical Trials Browser

Completed × Interventional × Disease Progression × Clear all

NCT04987203 2026-05-08

Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma

Phase 3 Completed

Carcinoma, Renal Cell, Disease Progression

NCT01191060 2026-04-06

IFM/DFCI2009

Phase 3 Completed

Disease Progression, Neoplasms, Plasma Cell

NCT02766699 2025-06-03

CerebralEDV

Phase 1 Completed

Brain Neoplasms, Glioblastoma, Neoplasms, Neoplasms by Site, Recurrence, Disease Progression

NCT01543763 2025-03-21

Pazopanib in Combination With PCI-24781 in Patients With Metastatic Solid Tumors

Phase 1 Completed

Neoplasm Metastasis, Sarcoma, Disease Progression

NCT03154190 2025-01-24

Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer

Phase NA Completed

128 enrolled 24 charts

BreastDermatologicGastrointestinalGenitourinaryGynecologicMyeloidOther hematologic neoplasmSarcomaThoracic

Urinary Bladder Neoplasms, Bone Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colonic Neoplasms, Esophageal Neoplasms, Melanoma, Myelodysplastic Syndromes, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Recurrence, Sarcoma, Stomach Neoplasms, Leukemia, Myeloid, Acute, Disease Progression, Triple Negative Breast Neoplasms

NCT01881620 2024-11-18

COMBITEP

Phase NA Completed

109 enrolled 12 charts

Disease Progression

NCT02043847 2024-11-13

BMT-03

Phase 1 Completed

12 enrolled 12 charts

Multiple Myeloma, Recurrence, Disease Progression

NCT03990571 2024-10-18

Axitinib and Avelumab in Treating Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma

Phase 2 Completed

40 enrolled 13 charts

Carcinoma, Adenoid Cystic, Disease Progression

NCT02135406 2023-06-22

CART-19 for Multiple Myeloma

Phase 1 Completed

Multiple Myeloma, Disease Progression

NCT01109004 2021-12-09

BMT CTN 0702

Phase 3 Completed

758 enrolled 21 charts

Hematologic Diseases, Multiple Myeloma, Disease Progression

NCT04723121 2021-01-25

Can We Predict of the Response of High Risk Non Muscle Invasive Bladder Cancer Patients to Intravesical Bacillus Calmette-Guerin? The Role of Immunological Markers

Phase NA Completed

Urinary Bladder Neoplasms, Recurrence, Disease Progression

NCT02322320 2020-05-11

Continued, Long-Term Follow-Up and Lenalidomide Maintenance Therapy for Patients on BMT CTN 0702 Protocol (BMT CTN 07LT)

Phase 3 Completed

273 enrolled 16 charts

Hematologic Diseases, Multiple Myeloma, Disease Progression

NCT00272350 2019-12-05

ZD6474 to Treat Advanced Brain Cancer in Patients

Phase 1 Completed

Brain Neoplasms, Glioma, Neoplasms, Disease Progression

NCT02189343 2019-11-21

Phase 1b Study Evaluating ACY-1215 (Ricolinostat) in Combination With Pomalidomide and Dexamethasone in Relapsed or Relapsed-and-Refractory Multiple Myeloma

Phase 1 Completed

Disease, Multiple Myeloma, Recurrence, Disease Progression

NCT03715660 2019-11-21

Xpert Bladder Cancer Monitor; Prospective, Single, Tertiary-care Center Implementation Study

Phase NA Completed

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Recurrence, Disease Progression

NCT02586987 2019-11-18

A Study to Assess the Safety, Tolerability and Anti-tumour Activity of Ascending Doses of Selumetinib in Combination With MEDI4736 and Selumetinib in Combination With MEDI4736 and Tremelimumab in Patients With Advanced Solid Tumours

Phase 1 Completed

BreastDermatologicGastrointestinalThoracic

Biliary Tract Neoplasms, Breast Neoplasms, Lung Neoplasms, Melanoma, Colorectal Neoplasms, Disease Progression

NCT01737450 2019-06-24

PIK-ORL

Phase 2 Completed

Head and Neck Neoplasms, Neoplasm Metastasis, Recurrence, Disease Progression

NCT03804866 2019-01-15

NGR-hTNF in Combination With an Anthracycline in Platinum-resistant Ovarian Cancer (NGR018)

Phase 2 Completed

Neoplasm Metastasis, Ovarian Neoplasms, Disease Progression

NCT01358071 2018-09-27

NGR018

Phase 2 Completed

Neoplasm Metastasis, Ovarian Neoplasms, Disease Progression

NCT02321202 2018-08-22

Omega-3 Fatty Acid-Based Parenteral Nutrition Improves Postoperative Recovery for Cirrhotic Patients With Liver Cancer

Phase 4 Completed

Gastrointestinal

Fibrosis, Hyperphagia, Liver Neoplasms, Disease Progression

NCT01355965 2017-09-19

Autologous Redirected RNA Meso-CIR T Cells

Phase 1 Completed

Other solid neoplasmThoracic

Mesothelioma, Malignant, Disease Progression

NCT03174912 2017-06-05

In the Prediction of Recurrence and Progression of NMIBC; EORTC or CUETO or Both?

Phase 4 Completed

Urinary Bladder Neoplasms, Recurrence, Disease Progression

NCT01886677 2017-03-03

Improving Energy Balance in Men With Prostate Cancer

Phase NA Completed

Motor Activity, Prostatic Neoplasms, Weight Loss, Disease Progression

NCT01110668 2017-02-28

Evaluation of Nilotinib In Patients With Advanced Gastrointestinal Stromal Tumor (GIST)

Phase 2 Completed

GastrointestinalSarcoma

Disease Progression, Gastrointestinal Stromal Tumors

NCT00995007 2016-03-29

A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas

Phase 2 Completed

112 enrolled 12 charts

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma, Disease Progression

NCT00108069 2015-11-05

Tamoxifen and Bortezomib to Treat Recurrent Brain Tumors

Phase 2 Completed

43 enrolled 11 charts

Brain Neoplasms, Glioma, Neoplasms, Disease Progression

NCT00908232 2015-01-15

SEQUENTIAL

Phase 2 Completed

163 enrolled 11 charts

Multiple Myeloma, Disease Progression, Bone Marrow Neoplasms

NCT01692262 2014-06-19

PYRUS

Phase 1 Completed

Prostatic Neoplasms, Disease Progression

NCT00517621 2011-02-25

Use of FACT-GOG/NTX Questionnaire in Peripheral Neurotoxicity & Validation of a French Version of This Questionnaire

Phase 2 Completed

Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms, Recurrence, Disease Progression

NCT00102414 2006-11-14

Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Ovarian Cancer

Phase 3 Completed

Ovarian Neoplasms, Recurrence, Disease Progression